...
rgls-img

Regulus Therapeutics Inc, Common Stock

RGLS

NAQ

$1.59

+$0.04

(2.58%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$101.53M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
441.41K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.63
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.08 L
$3 H
$1.59

About Regulus Therapeutics Inc, Common Stock

Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RGLS8429, an anti-miR next generation oligonucleotide targeting miR-17, which is in Phase 1b clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameRGLSSectorS&P500
1-Week Return0.63%-2.12%-3%
1-Month Return13.57%-3.42%-0.73%
3-Month Return-12.64%-11.13%2.87%
6-Month Return-36.9%-5.74%7.17%
1-Year Return20.45%3.97%25.31%
3-Year Return-52.71%1.05%28.38%
5-Year Return-75.16%34.37%81.89%
10-Year Return-99.92%97.88%183.27%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue6.83M10.01M10.02K--[{"date":"2019-12-31","value":68.28,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":0.1,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue12.35M15.35K459.00K122.00K21.15M[{"date":"2019-12-31","value":58.38,"profit":true},{"date":"2020-12-31","value":0.07,"profit":true},{"date":"2021-12-31","value":2.17,"profit":true},{"date":"2022-12-31","value":0.58,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit6.83M10.01M(459.00K)(122.00K)(21.15M)[{"date":"2019-12-31","value":68.28,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-4.59,"profit":false},{"date":"2022-12-31","value":-1.22,"profit":false},{"date":"2023-12-31","value":-211.39,"profit":false}]
Gross Margin100.00%100.00%(4579.92%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-4579.92,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses23.67M24.16M27.82M28.24M9.96M[{"date":"2019-12-31","value":83.81,"profit":true},{"date":"2020-12-31","value":85.56,"profit":true},{"date":"2021-12-31","value":98.5,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":35.26,"profit":true}]
Operating Income(16.83M)(14.15M)(27.82M)(28.24M)(31.11M)[{"date":"2019-12-31","value":-1683400000,"profit":false},{"date":"2020-12-31","value":-1415500000,"profit":false},{"date":"2021-12-31","value":-2781600000,"profit":false},{"date":"2022-12-31","value":-2823900000,"profit":false},{"date":"2023-12-31","value":-3110900000,"profit":false}]
Total Non-Operating Income/Expense(3.51M)(3.15M)18.00K(166.00K)2.04M[{"date":"2019-12-31","value":-171.92,"profit":false},{"date":"2020-12-31","value":-154.11,"profit":false},{"date":"2021-12-31","value":0.88,"profit":true},{"date":"2022-12-31","value":-8.12,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(18.59M)(15.73M)(27.81M)(28.32M)(30.04M)[{"date":"2019-12-31","value":-1859100000,"profit":false},{"date":"2020-12-31","value":-1573000000,"profit":false},{"date":"2021-12-31","value":-2780700000,"profit":false},{"date":"2022-12-31","value":-2832200000,"profit":false},{"date":"2023-12-31","value":-3003600000,"profit":false}]
Income Taxes1.00K(467.00K)1.00K1.00K1.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-46700,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(18.59M)(15.26M)(27.81M)(28.32M)(30.04M)[{"date":"2019-12-31","value":-1859200000,"profit":false},{"date":"2020-12-31","value":-1526300000,"profit":false},{"date":"2021-12-31","value":-2780800000,"profit":false},{"date":"2022-12-31","value":-2832300000,"profit":false},{"date":"2023-12-31","value":-3003700000,"profit":false}]
Income From Continuous Operations(18.59M)(15.73M)(27.81M)(28.32M)(28.77M)[{"date":"2019-12-31","value":-1859200000,"profit":false},{"date":"2020-12-31","value":-1573000000,"profit":false},{"date":"2021-12-31","value":-2780800000,"profit":false},{"date":"2022-12-31","value":-2832300000,"profit":false},{"date":"2023-12-31","value":-2877100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(18.59M)(15.26M)(27.81M)(28.32M)(30.04M)[{"date":"2019-12-31","value":-1859200000,"profit":false},{"date":"2020-12-31","value":-1526300000,"profit":false},{"date":"2021-12-31","value":-2780800000,"profit":false},{"date":"2022-12-31","value":-2832300000,"profit":false},{"date":"2023-12-31","value":-3003700000,"profit":false}]
EPS (Diluted)(11.00)(5.50)(3.30)(1.90)(1.59)[{"date":"2019-12-31","value":-1100,"profit":false},{"date":"2020-12-31","value":-550,"profit":false},{"date":"2021-12-31","value":-330,"profit":false},{"date":"2022-12-31","value":-190,"profit":false},{"date":"2023-12-31","value":-159,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

RGLS
Cash Ratio 13.47
Current Ratio 14.14

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

RGLS
ROA (LTM) -42.39%
ROE (LTM) -72.36%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

RGLS
Debt Ratio Lower is generally better. Negative is bad. 0.07
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.93

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

RGLS
Trailing PE NM
Forward PE NM
P/S (TTM) 7.43
P/B 1.20
Price/FCF NM
EV/R 0.66
EV/Ebitda 0.57
PEG NM

FAQs

What is Regulus Therapeutics Inc share price today?

Regulus Therapeutics Inc (RGLS) share price today is $1.59

Can Indians buy Regulus Therapeutics Inc shares?

Yes, Indians can buy shares of Regulus Therapeutics Inc (RGLS) on Vested. To buy Regulus Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RGLS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Regulus Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Regulus Therapeutics Inc (RGLS) via the Vested app. You can start investing in Regulus Therapeutics Inc (RGLS) with a minimum investment of $1.

How to invest in Regulus Therapeutics Inc shares from India?

You can invest in shares of Regulus Therapeutics Inc (RGLS) via Vested in three simple steps:

  • Click on Sign Up or Invest in RGLS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Regulus Therapeutics Inc shares
What is Regulus Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Regulus Therapeutics Inc (RGLS) is $3. The 52-week low price of Regulus Therapeutics Inc (RGLS) is $1.08.

What is Regulus Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Regulus Therapeutics Inc (RGLS) is

What is Regulus Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Regulus Therapeutics Inc (RGLS) is 1.20

What is Regulus Therapeutics Inc dividend yield?

The dividend yield of Regulus Therapeutics Inc (RGLS) is 0.00%

What is the Market Cap of Regulus Therapeutics Inc?

The market capitalization of Regulus Therapeutics Inc (RGLS) is $101.53M

What is Regulus Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Regulus Therapeutics Inc is RGLS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top